Literature DB >> 929118

Detection of sacro-ilitis. A comparison between profile scanning with the use of 99m Tc pertechnetate and scintigraphy with 99m Tc diphosphonate.

E Szanto, B Axelsson, N Lindvall.   

Abstract

Comparative evaluation of the sensitivity of 99mTc pertechnetate scanning and of 99mTc diphosphonate scintigraphy in detecting sacro-iliac arthritis (S.I.) was performed in 32 patients with definite S.I., 14 with probable S.I., and 6 with inactive S.I., 14 patients without any evidence of S.I. served as controls. Greater diagnostic accuracy was obtained by 99mTc pertechnetate scanning than with 99mTc diphosphonate scintigraphy in patients with active S.I. in the early stages before radiological changes had become evident and in patients 22 years old and younger. In patients with inactive S.I. a close correlation was found between clinical, radiological, and scintigraphical results with 99mTc diphosphonate scintigraphy. An index obtained by adding the uptake values measured by both methods in each subject yielded valuable information in patients with S.I. that is clinically difficult to differentiate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 929118     DOI: 10.3109/03009747709095436

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  3 in total

1.  Quantitative sacroiliac scintiscanning: a sensitive and objective method for assessing efficacy of nonsteroidal, anti-inflammatory drugs in patients with sacroiliitis.

Authors:  N A Dunn; B H Mahida; M V Merrick; G Nuki
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

2.  The thermographic pattern of the lower back with special reference to the sacro-iliac joints in health and inflammation.

Authors:  H Jacobsson; L Vestersköld
Journal:  Clin Rheumatol       Date:  1985-12       Impact factor: 2.980

Review 3.  Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022.

Authors:  Ann-Sophie De Craemer; Zuzanna Łukasik; Philippe Carron
Journal:  Curr Rheumatol Rep       Date:  2022-10-15       Impact factor: 4.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.